Halozyme Therapeutics Inc (NASDAQ:HALO)

15.30
Delayed Data
As of Apr 17
 -0.22 / -1.42%
Today’s Change
6.88
Today|||52-Week Range
16.55
+58.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues56.1M42.3M54.8M75.3M
 
 
 
 
 
Cost of Goods Sold257.8K1.1M5.0M21.0M
 
 
 
 
 
Depreciation And Amortization1.1M1.1M1.2M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income54.7M40.2M48.6M52.6M
 
 
 
 
 
General Expenses74.6M93.8M129.0M114.2M
 
 
 
 
 
Research And Development57.6M69.0M96.6M78.6M
 
 
 
 
 
Total Operating Expenses75.9M96.0M135.2M137.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.8M-53.6M-80.4M-61.6M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.4M
 
 
Interest Expense On Debt0.000.003.3M5.6M
 
 
 
Other Expenses5.6K14.4K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.8M-53.6M-83.5M-68.4M
 
 
 
 
 
Net Income-19.8M-53.6M-83.5M-68.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.6M111.1M112.8M122.7M
 
 
 
 
 
Shares To Calculate EPS Diluted102.6M111.1M112.8M122.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.48-$0.74-$0.56
 
 
 
 
 
EPS Diluted-$0.19-$0.48-$0.74-$0.56
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account